Weiyang He

1.4k total citations
40 papers, 1.0k citations indexed

About

Weiyang He is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Weiyang He has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 16 papers in Surgery and 12 papers in Cancer Research. Recurrent topics in Weiyang He's work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Weiyang He is often cited by papers focused on MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Weiyang He collaborates with scholars based in China, United States and United Kingdom. Weiyang He's co-authors include Xin Gou, Hubin Yin, Gongmin Zhu, Lin Fan, Xinyuan Li, Qifa Ye, Yanfeng Wang, Nian Liu, Lijiao Pei and Xin Gou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Weiyang He

39 papers receiving 1.0k citations

Peers

Weiyang He
Comparison fields: 5 of 96
  • Molecular Biology 715
  • Cancer Research 343
  • Surgery 181
  • Pulmonary and Respiratory Medicine 154
  • Immunology 92
Shenming Wang China
Jun Shi China
Weijie Du China
Ai Peng China
Mingwei Chen China
Yang Dong China
Tongyu Zhu China
Yuanjun Jiang China
Pingsheng Chen China
Shenming Wang China View profile →
Citations per field, relative to Weiyang He
Weiyang He · 1×
Citations per year, relative to Weiyang He
Weiyang He · 1×

Countries citing papers authored by Weiyang He

Since Specialization
Citations

This map shows the geographic impact of Weiyang He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiyang He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiyang He more than expected).

Fields of papers citing papers by Weiyang He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiyang He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiyang He. The network helps show where Weiyang He may publish in the future.

Co-authorship network of co-authors of Weiyang He

This figure shows the co-authorship network connecting the top 25 collaborators of Weiyang He. A scholar is included among the top collaborators of Weiyang He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiyang He. Weiyang He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Roles of Akirin1 in early prediction and treatment of graft kidney ischemia‒reperfusion injury SHILAP Revista de lepidopterología Xiang Zhou, Li Mao et al. 4
2 Identifying endoplasmic reticulum stress-related genes as new diagnostic and prognostic biomarkers in clear cell renal cell carcinoma Translational Andrology and Urology Haitao Yu, Chunlin Zhang et al. 2
3 Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia‒reperfusion injury by inducing ferroptosis propagation Cell Death and Differentiation Xinyuan Li, Xiang Zhou et al. 33
4 Development and validation of cancer-associated fibroblasts-related gene landscape in prognosis and immune microenvironment of bladder cancer Frontiers in Oncology Meng Zhang, Junlong Zhu et al. 4
5 YTHDF1 Promotes Bladder Cancer Cell Proliferation via the METTL3/YTHDF1–RPN2–PI3K/AKT/mTOR Axis International Journal of Molecular Sciences Junlong Zhu, Hang Tong et al. 21
6 EGF-induced nuclear translocation of SHCBP1 promotes bladder cancer progression through inhibiting RACGAP1-mediated RAC1 inactivation Cell Death and Disease Hubin Yin, Chen Zhang et al. 17
7 Secretory autophagy-induced bladder tumour-derived extracellular vesicle secretion promotes angiogenesis by activating the TPX2-mediated phosphorylation of the AURKA-PI3K-AKT axis Cancer Letters Zongjie Wei, Haitao Yu et al. 45
8 Assessment of Donor Liver Pathology Predicts Survival After Liver Transplantation: A Retrospective Cohort Study Transplantation Proceedings Shaojun Ye, Dongjing Liu et al. 2
9 miR-363 suppresses the proliferation, migration and invasion of clear cell renal cell carcinoma by downregulating S1PR1 Cancer Cell International Yongpeng Xie, Luyao Chen et al. 13
10 C1QTNF6 Overexpression Acts as a Predictor of Poor Prognosis in Bladder Cancer Patients BioMed Research International Xin Zhu, Hang Tong et al. 6
11 Exosomes from human‐bone‐marrow‐derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR‐199a‐3p Journal of Cellular Physiology Gongmin Zhu, Lijiao Pei et al. 126
12 Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression International Journal of Oncology Lin Fan, Hubin Yin et al. 107
13 SIRT3 a Major Player in Attenuation of Hepatic Ischemia‐Reperfusion Injury by Reducing ROS via Its Downstream Mediators: SOD2, CYP‐D, and HIF‐1α Oxidative Medicine and Cellular Longevity Xiaoli Fan, Weiyang He et al. 70
14 Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer Human Pathology Hubin Yin, Weiyang He et al. 17
15 Hypothermic oxygenated perfusion (HOPE) attenuates ischemia/reperfusion injury in the liver through inhibition of the TXNIP/NLRP3 inflammasome pathway in a rat model of donation after cardiac death The FASEB Journal Weiyang He, Shaojun Ye et al. 23
16 Hypothermic machine perfusion ameliorates inflammation during ischemia-reperfusion injury via sirtuin-1-mediated deacetylation of nuclear factor-κB p65 in rat livers donated after circulatory death Molecular Medicine Reports Cheng Zeng, Xiao Hu et al. 11
17 Celastrol protects kidney against ischemia–reperfusion-induced injury in rats Journal of Surgical Research Weiyang He, Youlin Kuang et al. 43
18 Laparoscopic radical cystectomy for bladder cancer with prostatic and neurovascular sparing: initial experience International Urology and Nephrology Xin Gou, Ming Wang et al. 1
19 Gene Silence-Induced Downregulation of Survivin Inhibits Bladder Cancer Cells Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics Xin Gou, Weiyang He et al. 4
20 [A new method for study of the effect of drugs on cancer cells--31PNMR with perfused cell system]. PubMed Weiyang He, Minjian Kong et al. 1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026